Table 4.
Clinical manifestations of COVID-19 recovered patients during discharge surveillance.
| Variables |
The 3rd day Number (%) |
The 7th day Number (%) |
The 14th day Number (%) |
|---|---|---|---|
| Loss to follow-up | 44 (13.1) | 36 (10.7) | 41 (12.2) |
| Clinical symptoms | |||
| Fever | 3 (0.9) | 1 (0.3) | 0 |
| Cough | 32 (9.5) | 46 (13.6) | 31 (9.2) |
| Expectoration | 12 (3.6) | 25 (7.4) | 21 (6.2) |
| Chest congestion | 15 (4.5) | 19 (5.6) | 28 (8.3) |
| Dyspnea | 7 (2.1) | 10 (3.0) | 7 (2.1) |
| Fatigue | 2 (0.6) | 3 (0.9) | 5 (1.5) |
| Myalgia | 1 (0.3) | 2 (0.6) | 1 (0.3) |
| Sore throat | 5 (1.5) | 7 (2.1) | 5 (1.5) |
| Nausea | 0 | 1 (0.3) | 1 (0.3) |
| Diarrhea | 9 (2.7) | 9 (2.7) | 4 (1.2) |
| Others | 9 (2.7) | 12 (3.6) | 14 (4.2) |
| Mental state | |||
| Spirit | 264 (78.3) | 248 (73.6) | 223 (66.2) |
| Full of hope | 25 (7.4) | 50 (14.8) | 56 (16.6) |
| Anxiety | 3 (0.3) | 3 (0.9) | 17 (5.0) |
| Depression | 1 (0.3) | 0 | 0 |
| Treatments in isolation areas | |||
| Chinese traditional medicine | 105 (31.2) | 205 (60.8) | 196 (58.2) |
| Lianhua qingwen capsule | 4 (1.2) | 2 (0.6) | 2 (0.6) |
| Antibiotics | 1 (0.3) | 5 (1.5) | 1 (0.3) |
| Antiviral therapy | 1 (0.3) | 3 (0.9) | 1 (0.3) |
| Isolation areas | |||
| Hotel | 177 (52.5) | 176 (52.2) | 136 (40.4) |
| School | 106 (31.5) | 118 (35.0) | 88 (26.1) |
| Community | 8 (2.4) | 5 (1.5) | 4 (1.2) |
| Home quarantine | 2 (0.6) | 2 (0.6) | 52 (15.4) |